This is well demonstrated by an upstream MaLR (THE1B) LTR sequence providing an alternative promoter to CSF1R in Hodgkin’s lymphoma, a B cell cancer [143]. The gene discussed is CSF1R; the disease is Hodgkins lymphoma.